Compare ANVS & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANVS | INVE |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 74.8M |
| IPO Year | 2019 | 1997 |
| Metric | ANVS | INVE |
|---|---|---|
| Price | $2.57 | $3.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $13.50 | $5.50 |
| AVG Volume (30 Days) | ★ 343.2K | 31.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.92 | ★ 1182.76 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $60,219,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.21 |
| 52 Week Low | $1.11 | $2.86 |
| 52 Week High | $5.50 | $4.07 |
| Indicator | ANVS | INVE |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 45.37 |
| Support Level | $2.27 | $3.17 |
| Resistance Level | $2.63 | $3.49 |
| Average True Range (ATR) | 0.20 | 0.19 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 40.20 | 22.73 |
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.